Vaccine used in Alberta not linked to blood clot issue in Europe: Hinshaw
Alberta’s chief medical officer of health says there is currently no indication that vaccination from some particular batches of AstraZeneca vaccine has caused blood clots among Albertans.
Dr. Deena Hinshaw said Thursday that the vaccine being used in Alberta is not linked to the issues being seen in Europe.
“We are currently using Covishield, the brand name of a vaccine produced by the Serum Institute of India that is considered equivalent to Astra Zeneca by Health Canada,” she said.
“Health Canada authorized these vaccines after independent and thorough scientific reviews for safety, efficacy and quality. And Canada has a robust surveillance system in place to detect rare occurrences following vaccination.”


